Akyerli, C. B.Özbek, U.Aydin-Sayitoǧlu, M.Sirma, S.Özçelik, T.2016-02-082016-02-0820030171-5216http://hdl.handle.net/11693/24423[No abstract available]EnglishAspartic acidCysteineGlycineMutant proteinProtein MYHTyrosineUnclassified drugAcute granulocytic leukemiaAcute lymphoblastic leukemiaArticleCancer riskChildhood leukemiaControlled studyDNA repairExcision repairGeneHumanMajor clinical studyMismatch repairMissense mutationMyh genePriority journalTurkey (republic)United kingdomChildDNA glycosylasesDNA, neoplasmEuropean continental ancestry groupHumansLeukemia, lymphocytic, acuteLeukemia, myelocytic, acuteMutationTurkeyAnalysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemiasArticle10.1007/s00432-003-0483-1